colitis and semaglutide What precautions should be taken when starting Wegovy (semaglutide) in a patient with a history of ulcerative colitis? What Experts Say About GLP-1s

The TRIUMPH-4 Phase 3 readout in April 2026 extended that to 28.7% at 68 weeks in a population with knee osteoarthritis - a patient group in whom weight loss produces disproportionate benefit on a secondary outcome (pain) the trial measured and reported as a 75.8% reduction on the WOMAC pain index

Persistent nausea and vomiting Serious cases can lead to dehydration and hospitalization

For the full picture of your out-of-pocket expenses, its best to chat with your insurance provider about Rybelsus coverage

Nutritional shifts during rapid weight loss may also reduce intake of essential fatty acids and minerals that support skin barrier integrity

Water weight fluctuations can mask fat loss during this period

p53 and the targeting approaches The tumor suppressor p53 is widely known as the genome guardian. Activated p53 binds to a specific DNA sequence as a tetramer to promote gene expression (such as CDKN1A , BAX , PUMA , and NOXA ), thus inducing cell apoptosis and cell-cycle arrest